Legislator Case Law & Legislation
812.212.21 VAMOMÉDOM CH AI generated

Art. 2 Ordinance of 21 September 2018 on Medicinal Products (OMéd) - Marketing Authorization

OMéd; Chapitre 2 Procédure d’autorisation de mise sur le marché
Open official source Full Act (94 Articles) Machine-readable Markdown (.md)

Legislator summary

AI generated

The marketing authorization for ready-to-use medicinal products is governed by Art. 9 of the Therapeutic Products Act (TPA). Authorization is required in all cases: a. for ready-to-use medicinal products that contain genetically modified organisms (GMOs); b. for standardized transplants as defined in Art. 2, para. 1, letter c, of the Ordinance of 16 March 2007 on Transplantation.

Art. 2 OMéd · Marketing Authorization

The marketing authorization for ready-to-use medicinal products is governed by Art. 9 of the Therapeutic Products Act (TPA).

Authorization is required in all cases

a. for ready-to-use medicinal products that contain genetically modified organisms (GMOs);

b. for standardized transplants as defined in Art. 2, para. 1, letter c, of the Ordinance of 16 March 2007 on Transplantation.

← Art. 1 OMéd Ordinance of 21 September 2018 on Medicinal Products (OMed) Art. 3 OMéd →

Need to analyze how this provision applies to your matter?

Cross-reference this statute against case law, commentaries, and related legislative provisions inside Legislator AI.

Open in Legislator →